Cold cereal with milk
The trial was funded by Eli Lilly
The most common side effects are gastrointestinal symptoms including nausea, vomiting, diarrhoea, and constipation, which are typically mild to moderate and improve with dose titration
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the First-in-Class GLP-1 and Amylin Receptor Agonist, Amycretin: A First-in-Human, Phase 1, Double-Blind, Randomised, Placebo-Controlled Trial
Combining the low doses with Noom's GLP-1 Companion support app "helps more patients stay on the treatment, experience the full health benefits of these medications, and make real progress in reducing obesity and overweight rates in the US," said the company's chief medical officer, Dr Jeffrey Egler
FDA 20262027